文献速递细菌感染、耐药与抗菌药物

培养非依赖系统(T2磁共振)检测血流感染患者可检测病原体的持续存在:预后作用及可能的临床意义

Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications.
PubMed 文献 · Clin Infect Dis · 2024-01-01

多中心前瞻性观察研究纳入102例血流感染患者,比较T2磁共振与血培养在4天随访内的血流清除时间,并探讨T2磁共振可检测病原体持续时间(MR-DNA血症)与临床结局的关联。T2磁共振清除时间显著长于血培养(HR 0.54,95%CI 0.39-0.75),MR-DNA血症每增加1天与持续感染风险升高相关,结论提示T2磁共振可能有助于诊断血培养阴性的血流感染及识别转移性感染等不良结局。

要点

  • T2磁共振检测的血流清除时间显著长于血培养(HR 0.54,95%CI 0.39-0.75)。
  • MR-DNA血症每增加1天,持续感染风险升高(总体OR 1.98,95%CI 1.45-2.70)。
  • MR-DNA血症持续时间与第7天SOFA评分无改善相关(OR 1.76,95%CI 1.21-2.56)。

核心结论

  • T2磁共振可能有助于诊断正在接受抗菌药物治疗且血培养阴性的血流感染患者,并识别转移性感染、感染源控制失败或短期不良结局的患者。
  • 未来研究可能有助于明确其在抗菌药物管理项目中的 usefulness。

研究设计与样本

  • 多中心、前瞻性、观察性研究,纳入102例血流感染患者。
  • 在4天随访内比较T2磁共振与血培养的血流清除时间。
  • 探讨T2磁共振可检测病原体持续时间(MR-DNA血症)与临床结局的关联。

主要发现

  • T2磁共振的血流清除时间显著长于血培养清除时间(HR 0.54,95%CI 0.39-0.75)。
  • T2磁共振清除时间不因致病病原体不同而存在差异(P=0.5)。
  • MR-DNA血症每增加1天,持续感染(定义为转移性感染或感染源控制延迟)的比值比在总体人群中为OR 1.98(95%CI 1.45-2.70),在金黄色葡萄球菌菌血症中为OR 1.92(95%CI 1.12-3.29),在革兰阴性菌菌血症中为OR 2.21(95%CI 1.35-3.60)。
  • MR-DNA血症持续时间与感染起病后第7天序贯器官衰竭评估评分无改善相关(OR 1.76,95%CI 1.21-2.56)。

临床怎么用

  • 原文结论指出,T2磁共振可能有助于诊断正在接受抗菌药物治疗且血培养阴性的血流感染患者,并识别转移性感染、感染源控制失败或短期不良结局的患者。
  • 原文结论指出,未来研究可能有助于明确其在抗菌药物管理项目中的 usefulness。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent Staphylococcus aureus bacteremia is associated with metastatic infection and adverse outcomes, whereas gram-negative bacteremia is normally transient and shorter course therapy is increasingly advocated for affected patients. Whether the prolonged detection of pathogen DNA in blood by culture-independent systems could have prognostic value and guide management decisions is unknown. METHODS: We performed a multicenter, prospective, observational study on 102 patients with bloodstream infection (BSI) to compare time to bloodstream clearance according to T2 magnetic resonance and blood cultures over a 4-day follow-up. We also explored the association between duration of detectable pathogens according to T2 magnetic resonance (magnetic resonance-DNAemia [MR-DNAemia]) and clinical outcomes. RESULTS: Time to bloodstream clearance according to T2 magnetic resonance was significantly longer than blood culture clearance (HR, .54; 95% CI, .39-.75) and did not differ according to the causative pathogen (P = .5). Each additional day of MR-DNAemia increased the odds of persistent infection (defined as metastatic infection or delayed source control) both in the overall population (OR, 1.98; 95% CI, 1.45-2.70) and in S. aureus (OR, 1.92; 95% CI, 1.12-3.29) and gram-negative bacteremia (OR, 2.21; 95% CI, 1.35-3.60). MR-DNAemia duration was also associated with no improvement in Sequential Organ Failure Assessment score at day 7 from infection onset (OR, 1.76; 95% CI, 1.21-2.56). CONCLUSIONS: T2 magnetic resonance may help diagnose BSI in patients on antimicrobials with negative blood cultures as well as to identify patients with metastatic infection, source control failure, or adverse short-term outcome. Future studies may inform its usefulness within the setting of antimicrobial stewardship programs.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Peri AM, O'Callaghan K, Rafiei N, et al. Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications. Clin Infect Dis. 2024. PMID: 37890109. doi:10.1093/cid/ciad663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。